We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
165 hedge funds and large institutions have $183M invested in Ginkgo Bioworks in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more call options, than puts
Call options by funds: $5.98M | Put options by funds: $3.75M
58% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 31
10% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 29
0% more funds holding
Funds holding: 165 → 165 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.75% less ownership
Funds ownership: 71.91% → 71.16% (-0.75%)
43% less capital invested
Capital invested by funds: $319M → $183M (-$136M)
Holders
165
Holders Change
–
Holders Change %
0%
% of All Funds
2.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
49
Reduced
31
Closed
29
Calls
$5.98M
Puts
$3.75M
Net Calls
+$2.22M
Net Calls Change
-$19.8M
Top Buyers
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$28.1M |
| 2 |
D.E. Shaw & Co
New York
|
-$5.37M |
| 3 |
Two Sigma Investments
New York
|
-$3.37M |
| 4 |
Two Sigma Advisers
New York
|
-$2.89M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.86M |
